Biomedical Potentialities of Silver Nanoparticles for Clinical Multiple Drug-Resistant Acinetobacter baumannii

Table 3

Drug-sensitive results for 38 patients with MDR-AB.

Drug	Number ()	Resistance rate (%)
Piperacillin	38	100
Piperacillin/tazobactam	38	100
Ampicillin/sulbactam	34	89.5
Imipenem	38	100
Meropenem	38	100
Ceftriaxone	38	100
Ceftazidime	38	100
Cefepime	38	100
Gentamicin	35	92.1
Tobramycin	35	92.1
Amikacin	35	92.1
Ciprofloxacin	38	100
Levofloxacin	22	57.9
Trimethoprim/sulfamethoxazole	18	47.4
Minocycline	0	0